-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Secretary of the Board of Directors Wu Chaoqun said in a telephone exchange on the 28th, after acceptance, the company will use the previous 3 workshops in parallel operation of 9 workshops to resume production, "should not have much impact on this year's entire production capacity."
" and will not carry out new material feeding between the government and the government between the completion of rectification and acceptance.
01 Income-generating 80% large plant to open 3 months of rectification it is understood that, as a professional engaged in research and development, production, sales of X-CT non-ionic shaper series and quinone series of raw materials and intermediates of high-tech enterprises, is the largest and most complete variety of domestic photocopicide generic products factory.
Steyrley company produced five API products iodized sea alcohol, iodine par alcohol, iodized kesha alcohol, left oxyfluorosa, hydrochloric acid left oxyfluorosa star to obtain the national drug GMP certificate;
data show that only 6 enterprises have obtained approval for the production of iodized sea alcohol raw materials, including Steyri, Anlikang, Jingfeng Pharmaceuticals, Beiland Pharmaceuticals, Zhejiang Haichang Pharmaceuticals and Taizhou Haisan Pharmaceuticals, of which Taizhou Haisan Pharmaceuticals and Zhejiang Haichang Pharmaceuticals were acquired by Staili and Bei lu Pharmaceuticals, respectively.
of Iodine sea alcohol RAW drug production capacity and output ranked first in the country.
2019, the production and sales of Staili iodized sea alcohol products are ranked first, with production of 5938 million kg and sales of 6678 million kg.
, and Steyri and Hengrui Pharmaceuticals, Bei lu Pharmaceuticals, Yangzijiang Pharmaceuticals, etc. have established cooperative relations.
the explosion could change the market landscape for iodized sea alcohols and ocytics.
as a leading company in the industry segment, Stai Li's listing has also been smooth sailing, with share prices soaring.
9, 2016, Staily landed on the A-share market.
at that time, the issue price was 12.15 yuan per share, with a total share value of 120 million shares and an estimate of 1,458 million yuan.
that at the beginning of the listing, Staili's share price exceeded 40 yuan.
the day before the explosion, the company's share price stood at 78.26 yuan per share, with a total market value of about 18.388 billion yuan.
about 12.61 times its valuation of $1,458 million on the eve of the listing.
and the outbreak of the accident for the Staily share price to rise the road pressed the pause button.
affected by the accident, Staili 28 word by word to stop the opening, as of the close, the stock price closed down the board, turnover of more than 130 million.
According to the annual report of Steyri, the operating income of iodized sea alcohol API in Xianli plant in 2019 was 359 million yuan, accounting for 27.49 percent of the company's total operating income, resulting in a gross profit of 132 million yuan, accounting for 23.52 percent of the company's overall gross profit.
2019, Xian Residential Plant achieved operating income of RMB 1,014 million, accounting for 77.51% of the Company's consolidated operating income, and net profit of RMB150 million, accounting for 82.25% of the Company's consolidated net profit.
, accounting for nearly 80% of the company's revenue of large factories for three months of shutdown and rectification, is bound to have an impact on the company's performance.
02 Frequent safety accidents The improvement of the quality of front-line personnel is imminent Although the cost is painful, but in recent years, there have been a number of pharmaceutical companies in China fire, explosion and other safety accidents, March 7, 2019, Jiangsu Snzhou Pharmaceutical Co., Ltd. explosion, resulting in 3 deaths, 7 injured, some equipment damage and house collapse, direct economic losses of about 8.42 million yuan.
The direct cause of the accident is that Sculhua synthetic second-line in order to improve the efficiency of raw material utilization, in the absence of demonstration and risk assessment, the use of existing glutamine production line stainless steel concentrate tank, and reference to the glutamine production process of the enrichment process for the concentration of axioms synthetic mother liquid, concentration post when During the process of concentration of Aximos synthetic mother fluid, the concentration time is too long, so that the temperature and concentration of the materials in the tank (including Aximos, Aximos synthetic raw materials 5-methyl pyridine-2-oxycoic acid and hydrogen peroxide, etc.) increase, resulting in a violent chemical reaction, causing an explosion.
October 31, 2018, Lizhu Group announced that a fire broke out in the 201-2 refining plant of Lizhu Group (Ningxia) Pharmaceutical Co., Ltd., a subsidiary of The Pingro Industrial Park in Shizushan City, Ningxia Hui Autonomous Region.
is not the first such incident at Liju Pharmaceuticals.
February 14, 2015, a fire broke out at Lizhu Pharmaceutical Group Ningxia Xinbeijiang Pharmaceutical Co., Ltd., causing burns to four people, with the most seriously injured persons with burns to their backs amounting to 34%.
The direct cause of the accident is: 14 at about 8 pm, the New Beijiang Pharmaceutical Industry 3 multi-functional tank, 4 foreign workers in the maintenance, fire operation illegal operation, resulting in the workshop combustible combustion, and the combustion process caused the system is partial leakage, further extending the combustion time.
of the above cases, mostly due to enterprises do not comply with the requirements of safe production, as well as illegal operation, and there are long-term problems of safe production.
, Wu Chaoqun, said the focus will be on workshop design control and personnel training.
According to Wu Chaoqun, the accident workshop design in 2005 or so, the use of fire-resistant materials, but did not carry out effective cell isolation, so once such an accident occurred, affecting the entire workshop.
Wu Chaoqun said that in the future, the source design, especially involving excessive solvent use or flammable and explosive chemicals of the use of reaction units to effectively isolate, as much as possible to reduce the scope of the impact of accidents.
In addition, Wu Chaoqun said that at present, the quality of most of the first-line operators in the industry stay in secondary, high school, college level, and even a small number of junior high school operators, in dealing with emergency operations, lack of professional knowledge, the future is the Group to strengthen efforts.
companies will also target the direction of environmental engineering, the recruitment of more professional background knowledge of the existing team to effectively upgrade.
.